Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
62.832,74
-1,42%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ T2 Biosystems Inc (TTOO) T2 Biosystems Inc (TTOO) Notizie

T2 Biosystems Inc

TTOO
2,81
0,07 (2,55%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202415:00GLOBET2 Biosystems to Report First Quarter 2024 Financial Results..
11/4/202422:05GLOBET2 Biosystems Shareholders Vote for CRG Debt Conversion into..
28/3/202414:00GLOBET2 Biosystems Announces Extension of Multi-Year Capital..
20/3/202412:30GLOBET2 Biosystems Unveils T2Lyme Launch Plans and Provides..
19/3/202414:00GLOBET2 Biosystems to Host Investor Call on March 20, 2024 to..
18/3/202414:00GLOBET2 Biosystems Announces New Publication Highlighting the..
12/3/202414:00GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
04/3/202422:34EDGAR2Form DEF 14A - Other definitive proxy statements
27/2/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:00EDGAR2Form 8-K - Current report
15/2/202422:49EDGAR2Form PRE 14A - Other preliminary proxy statements
15/2/202422:47EDGAR2Form 8-K - Current report
15/2/202422:06GLOBET2 Biosystems Announces Preliminary Fourth Quarter and Full..
15/2/202422:04GLOBET2 Biosystems Announces Agreement with CRG for the..
15/2/202422:02GLOBET2 Biosystems Announces Commercial Expansion Through..
14/2/202402:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202415:00GLOBET2 Biosystems Receives FDA 510(k) Clearance for the Expanded..
07/2/202422:05GLOBET2 Biosystems to Report Fourth Quarter and Full Year 2023..
18/1/202415:00GLOBET2 Biosystems Announces Participation in NIH-funded..
05/1/202422:00EDGAR2Form 8-K - Current report
03/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:00GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand Use..
28/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
24/11/202322:30EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202314:00GLOBET2 Biosystems to Participate in the Canaccord Genuity..
01/11/202314:08EDGAR2Form 8-K - Current report
01/11/202314:00GLOBET2 Biosystems Regains Compliance with Nasdaq Listing..
25/10/202315:02EDGAR2Form 8-K - Current report
24/10/202322:05GLOBET2 Biosystems Highlights New Clinical Data Presented at..
23/10/202315:00EDGAR2Form 8-K - Current report
23/10/202315:00GLOBET2 Biosystems Announces Amendment and Extension of CRG Term..
20/10/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202322:31EDGAR2Form 8-K - Current report
12/10/202322:32EDGAR2Form 8-K - Current report
12/10/202322:05GLOBET2 Biosystems Announces Preliminary Third Quarter 2023..
12/10/202322:02GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand the..
12/10/202322:01EDGAR2Form 8-K - Current report
12/10/202315:00GLOBET2 Biosystems Announces Reverse Stock Split Effective Today
11/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,76 Min: 2,7001 Max: 2,9353
Chiusura: 2,74

La tua Cronologia

NASDAQ
TTOO
T2 Biosystems
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network